Gainers:
THC: +3.8%, 10k - joint venture w/United Surgical Partners
TEVA: +1.7%, 108k - Migraine study meets endpoints
Losers:
VRTX: -6%, 242k - disappointing data on drug
KSU: -3.8%, 751 - lowered FY 2015 sales growth
NVDA: -3%, 14k
LULU: -2.3%, 11.5k
GILD: -2%, 562k - HCV news
MON: -1.7%, -12.2k - herbicide likely carcinogenic
No comments:
Post a Comment